Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review

B B Thompson; Y Béjot; V Caso; Jaime Castillo; Hanne Krarup Christensen; M L Flaherty; C Foerch; K Ghandehari; M Giroud; S M Greenberg; H Hallevi; J C Hemphill; P Heuschmann; S Juvela; K Kimura; P K Myint; Y Nagakane; H Naritomi; S Passero; M R Rodríguez-Yáñez; J Roquer; J Rosand; N S Rost; P Saloheimo; V Salomaa; J Sivenius; T Sorimachi; M Togha; K Toyoda; W Turaj; K N Vemmos; C D A Wolfe; D Woo; E E Smith

doi:10.1212/WNL.0b013e3181f735e5

Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review

B B Thompson, Y Béjot, V Caso, Jaime Castillo, Hanne Krarup Christensen, M L Flaherty, C Foerch, K Ghandehari, M Giroud, S M Greenberg, H Hallevi, J C Hemphill, P Heuschmann, S Juvela, K Kimura, P K Myint, Y Nagakane, H Naritomi, S Passero, M R Rodríguez-YáñezJ Roquer, J Rosand, N S Rost, P Saloheimo, V Salomaa, J Sivenius, T Sorimachi, M Togha, K Toyoda, W Turaj, K N Vemmos, C D A Wolfe, D Woo, E E Smith

Neurologisk Afd. N

163 Citationer (Scopus)

Abstract

Antiplatelet therapy (APT) promotes bleeding; therefore, APT might worsen outcome in patients with intracerebral hemorrhage (ICH). We performed a systematic review and meta-analysis to address the hypothesis that pre-ICH APT use is associated with mortality and poor functional outcome following ICH.

Originalsprog	Engelsk
Tidsskrift	Neurology
Vol/bind	75
Udgave nummer	15
Sider (fra-til)	1333-42
Antal sider	10
DOI	https://doi.org/10.1212/WNL.0b013e3181f735e5
Status	Udgivet - 12 okt. 2010

Adgang til dokumentet

10.1212/WNL.0b013e3181f735e5

Citationsformater

Thompson, B. B., Béjot, Y., Caso, V., Castillo, J., Christensen, H. K., Flaherty, M. L., Foerch, C., Ghandehari, K., Giroud, M., Greenberg, S. M., Hallevi, H., Hemphill, J. C., Heuschmann, P., Juvela, S., Kimura, K., Myint, P. K., Nagakane, Y., Naritomi, H., Passero, S., ... Smith, E. E. (2010). Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology, 75(15), 1333-42. https://doi.org/10.1212/WNL.0b013e3181f735e5

Thompson, BB, Béjot, Y, Caso, V, Castillo, J, Christensen, HK, Flaherty, ML, Foerch, C, Ghandehari, K, Giroud, M, Greenberg, SM, Hallevi, H, Hemphill, JC, Heuschmann, P, Juvela, S, Kimura, K, Myint, PK, Nagakane, Y, Naritomi, H, Passero, S, Rodríguez-Yáñez, MR, Roquer, J, Rosand, J, Rost, NS, Saloheimo, P, Salomaa, V, Sivenius, J, Sorimachi, T, Togha, M, Toyoda, K, Turaj, W, Vemmos, KN, Wolfe, CDA, Woo, D & Smith, EE 2010, 'Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review', Neurology, bind 75, nr. 15, s. 1333-42. https://doi.org/10.1212/WNL.0b013e3181f735e5

@article{4dcf9ad640e24ac7acd9c183bd473e5c,

title = "Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review",

abstract = "Antiplatelet therapy (APT) promotes bleeding; therefore, APT might worsen outcome in patients with intracerebral hemorrhage (ICH). We performed a systematic review and meta-analysis to address the hypothesis that pre-ICH APT use is associated with mortality and poor functional outcome following ICH.",

author = "Thompson, {B B} and Y B{\'e}jot and V Caso and Jaime Castillo and Christensen, {Hanne Krarup} and Flaherty, {M L} and C Foerch and K Ghandehari and M Giroud and Greenberg, {S M} and H Hallevi and Hemphill, {J C} and P Heuschmann and S Juvela and K Kimura and Myint, {P K} and Y Nagakane and H Naritomi and S Passero and Rodr{\'i}guez-Y{\'a}{\~n}ez, {M R} and J Roquer and J Rosand and Rost, {N S} and P Saloheimo and V Salomaa and J Sivenius and T Sorimachi and M Togha and K Toyoda and W Turaj and Vemmos, {K N} and Wolfe, {C D A} and D Woo and Smith, {E E}",

year = "2010",

month = oct,

day = "12",

doi = "10.1212/WNL.0b013e3181f735e5",

language = "English",

volume = "75",

pages = "1333--42",

journal = "Neurology",

issn = "1526-632X",

publisher = "Lippincott Williams & Wilkins",

number = "15",

}

TY - JOUR

T1 - Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review

AU - Thompson, B B

AU - Béjot, Y

AU - Caso, V

AU - Castillo, Jaime

AU - Christensen, Hanne Krarup

AU - Flaherty, M L

AU - Foerch, C

AU - Ghandehari, K

AU - Giroud, M

AU - Greenberg, S M

AU - Hallevi, H

AU - Hemphill, J C

AU - Heuschmann, P

AU - Juvela, S

AU - Kimura, K

AU - Myint, P K

AU - Nagakane, Y

AU - Naritomi, H

AU - Passero, S

AU - Rodríguez-Yáñez, M R

AU - Roquer, J

AU - Rosand, J

AU - Rost, N S

AU - Saloheimo, P

AU - Salomaa, V

AU - Sivenius, J

AU - Sorimachi, T

AU - Togha, M

AU - Toyoda, K

AU - Turaj, W

AU - Vemmos, K N

AU - Wolfe, C D A

AU - Woo, D

AU - Smith, E E

PY - 2010/10/12

Y1 - 2010/10/12

N2 - Antiplatelet therapy (APT) promotes bleeding; therefore, APT might worsen outcome in patients with intracerebral hemorrhage (ICH). We performed a systematic review and meta-analysis to address the hypothesis that pre-ICH APT use is associated with mortality and poor functional outcome following ICH.

AB - Antiplatelet therapy (APT) promotes bleeding; therefore, APT might worsen outcome in patients with intracerebral hemorrhage (ICH). We performed a systematic review and meta-analysis to address the hypothesis that pre-ICH APT use is associated with mortality and poor functional outcome following ICH.

U2 - 10.1212/WNL.0b013e3181f735e5

DO - 10.1212/WNL.0b013e3181f735e5

M3 - Journal article

C2 - 20826714

SN - 1526-632X

VL - 75

SP - 1333

EP - 1342

JO - Neurology

JF - Neurology

IS - 15

ER -

Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater